Zhang, N., Du, Y., Yu, Y., Wu, Q., Bai, W., Zhang, W., Zhang, S., Zhu, W., Yu, H., Liu, X., Luo, M., Liu, H., Zhang, Y., Liu, K., Huo, Y., Han, G., Yu, H., Hao, J., Lu, W. (2025). Transarterial chemoembolization combined with atezolizumab plus bevacizumab versus transarterial chemoembolization combined with lenvatinib plus sintilimab as first-line therapy for advanced hepatocellular carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16223